Irving Kahn - Kahn Brothers Group
Holding/activity history for GSK plc (GSK)
← All GSK superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 160,982 | 1.58 | Reduce 9.91% | 0.15 | $49.39–59.57 · VW $53.17i | $8,884,596 | SEC |
| 2025 Q4 | 178,696 | 1.55 | Reduce 31.49% | 0.67 | $47.13–61.70 · VW $55.99i | $8,763,251 | SEC |
| 2025 Q3 | 260,837 | 2.12 | Reduce 60.47% | 3.08 | $38.63–48.69 · VW $45.06i | $11,257,724 | SEC |
| 2025 Q2 | 659,872 | 5.09 | Buy | 5.09 | $35.45–42.63 · VW $39.25i | $25,339,084 | SEC |
Price snapshot:
Current price$52.29
Avg. buy price$38.40
+/- since buy36.17%
52-week low$34.17
52-week high$60.65